As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of ...

Self-managed teams democratize the world of work by empowering employees. With management ranks flattening, high-growth ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Ed Field discovered his passion for building biotechnology innovation while working with an equity-backed biopharma start-up ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Rates of myalgic encephalomyelitis/chronic fatigue syndrome have dramatically increased since pre-pandemic times. A new large ...

Racism and politics played a part in how we viewed them.” By Philippa Martyr, University of Western Australia Cannabis, ...

Bayer now says it expects to make €3 billion ... results of the phase 3 ARASENS trial in the New England Journal of Medicine. The study showed that adding Nubeqa to standard therapy with anti ...